Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT05712473

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05712473. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 17, 2026, 4:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Multicenter Real-World Registry Assessing the Impact of the Use of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this observational research is to assess the real-world clinical utility of PYLARIFY PET through evaluation of long-term outcomes for prostate cancer patients who are eligible for a PSMA/PET scan. Participants will be enrolled at their physician's office at the time of referral for PYLARIFY PET and will be followed for up to 5 years. Data concerning their prostate cancer diagnostics and treatment will be collected at 6-month intervals.

Study identification

NCT ID
NCT05712473
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Lantheus Medical Imaging
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
21 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2023 (Actual)
Primary completion
Feb 2031 (Estimated)
Completion
May 2031 (Estimated)
Last update posted
Sep 15, 2026

2023 – 2031

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209 —
Arkansas Urology Little Rock Arkansas 72211 —
Urology Associates of Central California Fresno California 93720 —
Comprehensive Urology Medical Group Los Angeles California 90048 —
Pasadena Urological Medical Group Pasadena California 91101 —
Comprehensive Urology Royal Oak Michigan 48076 —
Urology of St. Louis St Louis Missouri 63141 —
Adult & Pediatric Urology Omaha Nebraska 68114 —
Keystone Urology Specialists Lancaster Pennsylvania 17604 —
Urology Associates Nashville Nashville Tennessee 37209 —
Potomac Urology Alexandria Virginia 22311 —
Urology of Virginia Virginia Beach Virginia 23462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05712473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2026 · Synced Nov 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.